This immunotherapy clinical trial has already helped change the way the deadly skin cancer Merkel cell carcinoma is treated. Its latest results published today in JCOASCO highlight longterm results the investigators are calling "thrilling." https

This #immunotherapy clinical trial has already helped change the way the deadly skin cancer Merkel cell carcinoma is treated. Its latest results, published today in @JCO_ASCO, highlight long-term results the investigators are calling "thrilling." https://

16:40 EST 6 Feb 2019 | Odi Bruckman

This #immunotherapy clinical trial has already helped change the way the deadly skin cancer Merkel cell carcinoma is treated. Its latest results, published today in @JCO_ASCO, highlight long-term results the investigators are calling "thrilling." https://bit.ly/2t8OcR5 

More From BioPortfolio on "This #immunotherapy clinical trial has already helped change the way the deadly skin cancer Merkel cell carcinoma is treated. Its latest results, published today in @JCO_ASCO, highlight long-term results the investigators are calling "thrilling." https://"